• Home Blog Tag Immune thrombocytopenia market

Immune Thrombocytopenia Market

Sep 02, 2025

FDA Approves Eisai & Biogen’s LEQEMBI IQLIK for Maintenance Treatment of Early Alzheimer’s; Travere Therapeutics Gains FDA Nod for FILSPARI REMS Update in IgA Nephropathy; Vanda Pharmaceuticals’ VGT-1849B Granted FDA Orphan Drug Status for Polycythemia Vera; Teva Launches First FDA-Approved Generic SAXENDA for Weight Loss; Sanofi’s WAYRILZ Gets FDA Approval as First BTK Inhibitor for Immune Thrombocytopenia

May 25, 2020

R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia

Newsletter/Whitepaper